NO20012834L - Acetamid- og substituerte acetamid-holdige tioureainhibitorer for herpesvirus - Google Patents

Acetamid- og substituerte acetamid-holdige tioureainhibitorer for herpesvirus

Info

Publication number
NO20012834L
NO20012834L NO20012834A NO20012834A NO20012834L NO 20012834 L NO20012834 L NO 20012834L NO 20012834 A NO20012834 A NO 20012834A NO 20012834 A NO20012834 A NO 20012834A NO 20012834 L NO20012834 L NO 20012834L
Authority
NO
Norway
Prior art keywords
carbon atoms
alkyl
perhaloalkyl
aryl
hydrogen
Prior art date
Application number
NO20012834A
Other languages
English (en)
Other versions
NO20012834D0 (no
Inventor
Jonathan David Bloom
Martin Joseph Digrandi
Russel George Dushin
Stanley Albert Lang
Bryan Mark O'hara
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of NO20012834D0 publication Critical patent/NO20012834D0/no
Publication of NO20012834L publication Critical patent/NO20012834L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04Derivatives of thiourea
    • C07C335/16Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/20Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04Derivatives of thiourea
    • C07C335/16Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/22Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

Forbindelser med formelen: hvori RrRs uavhengig er valgt fra hydrogen, alkyl med 1 til 6 karbonatomer, alkenyl med 2 til 6 karbonatomer, alkynyl med 2 til 6 karbonatomer, perhalogenalkyl med 1 til 6 karbonatomer. cykloalkyl med 3 til 10 karbonatomer. heterocykloalkyl med 3 til 10 karbonelementer. aryl. heteroaryl. halogen. -CN. -NO* -COzR8. -CORe. -OR6. -SR6. -SOR,. -SOjRa. -CONR7R.. -NR«N(R7FU). -N(R7R«) eller W-Y-(CH2)n-Z forutsatt at minst en av R,-RS ikke er hydrogen; eller R2 og Rs eller R3 og R«, tilsammen danner en 3- til 7-leddet heterocykloalkyl eller 3- til 7-leddet heteroaryl; R« og R7 er uavhengig hydrogen, alkyl med 1 til 6 karbonatomer. perhalogenalkyl med 1 til 6 karbonatomer eller aryl; R» er hydrogen, alkyl med 1 til 6 karbonatomer. perhalogenalkyl med 1 til 6 karbonatomer. cykloalkyl med 3 til 10 karbon- atomer. heterocykloalkyl med 3 til 10 elementer, aryl eller heteroaryl. eller R7 og Rg, danner sammen en 3- til 7-leddet heterocykloalkyl; R,rR12 er uavhengig hydrogen, alkyl med 1 til 4 karbonatomer, perhalogenalkyl med 1 til 4 karbonatomer. halogen, alkoksy med 1 til 4 karbonatomer eller cyano eller R» og R10 eller R,, og R12 kan sammen danne aryl med 5 til 7 karbonatomer; W er O. NR6 eller mangler; Y er -(CO)- eller -(CO2)- eller mangler; Z er alkyl med 1 til 4 karbonatomer, -CN, -CO2R8, COR6, -CONR7R8, -OCOR6, -NR6COR7, -OCONR,,. -OR«, -SRa. -SOR«, -S02R6, SR6N(R7R8), -N(R7R8) eller fenyl; G er alkyl med 1 til 6 karbon- atomer; og X er en binding, -NH. alkyl med 1 til 6 karbonatomer, alkenyl med 1 til 6 karbon- atomer, alkoksy med 1 til 6 karbonatomer, tioalkyl med 1 til 6 karbonatomer, alkylamino med 1 til 6 karbonatomer eller (CH)J; J er alkyl med 1 til 6 karbonatomer, cykloalkyl med 3 til 7 karbonatomer. fenyl eller benzyl; og n er et heltall fra 1 til 6; eller farmasøytiske salter derav, er anvendelige ved behandling av sykdommer i forbindelse med herpesvirus innbefattet human cytomegalovirus, herpes simplex virus, Epstein-Barr virus, varicella-zoster virus, human herpesvirus-6 og -7 og Kapsosi herpesvirus.
NO20012834A 1998-12-09 2001-06-08 Acetamid- og substituerte acetamid-holdige tioureainhibitorer for herpesvirus NO20012834L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20831698A 1998-12-09 1998-12-09
PCT/US1999/028844 WO2000034237A2 (en) 1998-12-09 1999-12-06 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses

Publications (2)

Publication Number Publication Date
NO20012834D0 NO20012834D0 (no) 2001-06-08
NO20012834L true NO20012834L (no) 2001-08-07

Family

ID=22774137

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012834A NO20012834L (no) 1998-12-09 2001-06-08 Acetamid- og substituerte acetamid-holdige tioureainhibitorer for herpesvirus

Country Status (15)

Country Link
EP (1) EP1137633A2 (no)
JP (1) JP2002531544A (no)
KR (1) KR20010087413A (no)
CN (1) CN1333750A (no)
AU (1) AU3111200A (no)
BR (1) BR9916041A (no)
CA (1) CA2350899A1 (no)
CZ (1) CZ20012060A3 (no)
EA (1) EA200100640A1 (no)
HU (1) HUP0104944A3 (no)
IL (1) IL143204A0 (no)
NO (1) NO20012834L (no)
PL (1) PL349131A1 (no)
WO (1) WO2000034237A2 (no)
ZA (1) ZA200104142B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6166028A (en) * 1998-12-09 2000-12-26 American Home Products Corporation Diaminopuridine-containing thiourea inhibitors of herpes viruses
US6844367B1 (en) 1999-09-17 2005-01-18 Millennium Pharmaceuticals, Inc. Benzamides and related inhibitors of factor Xa
DK1259485T3 (da) 2000-02-29 2006-04-10 Millennium Pharm Inc Benzamider og beslægtede inhibitorer for faktor Xa
RU2005115842A (ru) * 2002-10-24 2006-03-10 Мерк Патент ГмбХ (DE) Производные метиленмочевины
US7220768B2 (en) * 2003-02-11 2007-05-22 Wyeth Holdings Corp. Isoxazole-containing thiourea inhibitors useful for treatment of varicella zoster virus
WO2005014825A2 (en) 2003-08-08 2005-02-17 Arriva Pharmaceuticals, Inc. Methods of protein production in yeast
CN100554249C (zh) 2003-08-29 2009-10-28 三井化学株式会社 农园艺用杀虫剂及其使用方法
US7914771B2 (en) 2004-03-09 2011-03-29 Arriva Pharmaceuticals, Inc. Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor
EP2074085A2 (en) * 2006-10-13 2009-07-01 Lica Pharmaceuticals A/S Anti-infective thiourea compounds
ES2382055T3 (es) 2006-11-02 2012-06-04 Millennium Pharmaceuticals, Inc. Métodos para sintetizar sales farmacéuticas de un inhibidor del factor Xa
CN108619123A (zh) * 2018-03-13 2018-10-09 武汉威立得生物医药有限公司 Tenovin-1在制备防治人类疱疹病毒感染药物中的应用
WO2019193541A1 (en) * 2018-04-06 2019-10-10 Glaxosmithkline Intellectual Property Development Limited Bicyclic aromatic ring derivatives of formula (i) as atf4 inhibitors
CN112807294B (zh) * 2019-11-18 2023-09-05 武汉大学 一种酰基硫脲类化合物在制备治疗或预防单纯疱疹病毒i型感染药物中的应用
WO2022150962A1 (en) * 2021-01-12 2022-07-21 Westlake Pharmaceutical (Hangzhou) Co., Ltd. Protease inhibitors, preparation, and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69811062T2 (de) * 1997-04-10 2003-07-17 Upjohn Co Polyaromatische antivirale zusammensetzungen

Also Published As

Publication number Publication date
HUP0104944A3 (en) 2003-03-28
EP1137633A2 (en) 2001-10-04
ZA200104142B (en) 2002-10-25
AU3111200A (en) 2000-06-26
CZ20012060A3 (cs) 2001-11-14
HUP0104944A2 (hu) 2002-04-29
EA200100640A1 (ru) 2001-12-24
CA2350899A1 (en) 2000-06-15
IL143204A0 (en) 2002-04-21
BR9916041A (pt) 2001-12-04
PL349131A1 (en) 2002-07-01
JP2002531544A (ja) 2002-09-24
WO2000034237A2 (en) 2000-06-15
CN1333750A (zh) 2002-01-30
NO20012834D0 (no) 2001-06-08
KR20010087413A (ko) 2001-09-15
WO2000034237A3 (en) 2000-11-23

Similar Documents

Publication Publication Date Title
NO20012834L (no) Acetamid- og substituerte acetamid-holdige tioureainhibitorer for herpesvirus
EA200000993A1 (ru) Тризамещенные производные 1,3,5-триазина для лечения вич-инфекционных заболеваний
ATE11535T1 (de) N-heteroaryl-alkylendiamine, verfahren zu ihrer herstellung sowie ihre verwendung.
WO2000034258A3 (en) Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
UA50725C2 (uk) Похідні 2-[(2-алкокси-6-трифторметилпіримідин-4-іл)оксиметилен]- фенілоцтової кислоти, спосіб їх отримання, застосування піримідин-4-олів для отримання цих похідних та засіб для боротьби зі шкідниками
DE69108299T2 (de) Antiherpes-Peptidderivate mit einem 1,4-Dioxo-C4-N-Terminus.
WO2000034261A3 (en) Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing a substituted phenylenediamine group
BG105583A (en) Thiourea as inhibitor of herpes viruses
NO20012837L (no) Tiourea-inhibitorer for herpesvirus
WO2000034260A3 (en) Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group
DK568088D0 (da) 3,5-dihydroxy-6,8-nonadiensyre-forbindelser og farmaceutiske praeparater indeholdende disse samt 5-hydroxy-3-oxo-6,8-nonadiensyreester-forbindelser til anvendelse som udgangsmateriale ved deres fremstilling
BR9916042A (pt) Composto, composição farmacêutica, e, processospara inibir a replicação de um vìrus herpes, e detratamento de um paciente que sofra de umainfecção do vìrus herpes
LTIP912A (en) Indenoindole copounds ii, process for preraring them and pharmaceutical composition containing them
CA2301967A1 (en) Azetidinone derivatives for the treatment of hcmv infections
NO940019L (no) Fremgangsmåte for fremstilling av svovelholdige imidazolderivater
CA2301543A1 (en) Azetidinone derivatives for the treatment of hcmv infections
DK0570245T3 (da) Octahydronaphthalenoximderivater til inbibering af kolesterolbiosyntese, deres fremstilling og anvendelse
KR900003165A (ko) 2-아미노-4-모르폴리노-6-프로필-1,3,5-트리아진
DE69014337D1 (de) Verwendung von 5-Alkylpyridazin-Derivaten als Medikamente zur Beeinflussung des cholinergen Systems.
ATE168995T1 (de) N-(mercaptoacyl)aminosäure, ihre herstellung, ihre therapeutische verwendung und sie enthaltende pharmazeutische zusammensetzungen
RU2032674C1 (ru) Вещество, обладающее противогерпесным действием
FI953246A (fi) Välituotteet kinoliini-3-karboksyylihappojohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application